◆英語タイトル：Syros Pharmaceuticals Inc (SYRS) - Financial and Strategic SWOT Analysis Review
Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used to treat patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and SY-1365, a potent and selective small molecule inhibitor of CDK7 that is used to treat patients with transcriptionally driven solid tumors and acute leukemias. Syors provides gene regulation, new medicines development, proprietary drug development platform, and integrated gene control assay technologies. Its gene control platform identifies novel gene control targets linked to genomically defined patient populations, and drugging gene control targets. The company partners with other biopharmaceutical companies to extend the potential of our gene control platform across multiple therapeutic areas and diseases. Syros is headquartered in Cambridge, Massachusetts, the US.
Syros Pharmaceuticals Inc Key Recent Developments
Dec 02,2018: Syros Announces Promising Clinical Data from Ongoing Phase 2 Trial of SY-1425 in Genomically Defined AML and MDS Patients at ASH Annual Meeting
Nov 13,2018: Syros Presents New Preclinical Combination Data on SY-1365 and First Preclinical Data from Oral CDK7 Inhibitor Program at EORTC-NCI-AACR Meeting
Nov 01,2018: Syros to Present Initial Clinical Data from Combination Cohorts in Its Ongoing Phase 2 Trial of SY-1425 at ASH Annual Meeting
Nov 01,2018: Syros reports third quarter 2018 financial results and highlights key accomplishments and upcoming milestones
Oct 30,2018: Syros to Present Clinical and Preclinical Data on SY-1365 and Earlier-Stage Pipeline at EORTC-NCI-AACR Meeting
This comprehensive SWOT profile of Syros Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Syros Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Syros Pharmaceuticals Inc – Key Information
Syros Pharmaceuticals Inc – Overview
Syros Pharmaceuticals Inc – Key Employees
Syros Pharmaceuticals Inc – Key Employee Biographies
Syros Pharmaceuticals Inc – Key Operational Heads
Syros Pharmaceuticals Inc – Major Products and Services
Syros Pharmaceuticals Inc – History
Syros Pharmaceuticals Inc – Company Statement
Syros Pharmaceuticals Inc – Locations And Subsidiaries
Syros Pharmaceuticals Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Syros Pharmaceuticals Inc – Business Description
Syros Pharmaceuticals Inc – Corporate Strategy
Syros Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Syros Pharmaceuticals Inc – Strengths
Syros Pharmaceuticals Inc – Weaknesses
Syros Pharmaceuticals Inc – Opportunities
Syros Pharmaceuticals Inc – Threats
Syros Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Syros Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Syros Pharmaceuticals Inc, Key Information
Syros Pharmaceuticals Inc, Key Ratios
Syros Pharmaceuticals Inc, Share Data
Syros Pharmaceuticals Inc, Major Products and Services
Syros Pharmaceuticals Inc, History
Syros Pharmaceuticals Inc, Key Employees
Syros Pharmaceuticals Inc, Key Employee Biographies
Syros Pharmaceuticals Inc, Key Operational Heads
Syros Pharmaceuticals Inc, Other Locations
Syros Pharmaceuticals Inc, Subsidiaries
Syros Pharmaceuticals Inc, Key Manufacturing facilities
Syros Pharmaceuticals Inc, Key Competitors
Syros Pharmaceuticals Inc, SWOT Analysis
Syros Pharmaceuticals Inc, Ratios based on current share price
Syros Pharmaceuticals Inc, Annual Ratios
Syros Pharmaceuticals Inc, Interim Ratios
Capital Market Ratios
List of Figures
Syros Pharmaceuticals Inc, Performance Chart
Syros Pharmaceuticals Inc, Ratio Charts
| ★海外企業調査レポート[Syros Pharmaceuticals Inc (SYRS)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら